Abrogating fibrinolysis does not improve bleeding or rFVIIa/rFVIII treatment in a non-mucosal venous injury model in haemophilic rodents-Reference-Cited by-同舟云学术

Abrogating fibrinolysis does not improve bleeding or rFVIIa/rFVIII treatment in a non-mucosal venous injury model in haemophilic rodents

Published:2018-06-21 Issue:7 Volume:16 Page:1369-1382
ISSN:1538-7933
Container-title:Journal of Thrombosis and Haemostasis
language:en
Short-container-title:J Thromb Haemost

Author:

Stagaard R.¹²³,Flick M. J.³,Bojko B.⁴,Goryński K.⁴,Goryńska P. Z.⁴,Ley C. D.¹,Olsen L. H.²,Knudsen T.¹

Affiliation:

1. Global Drug Discovery; Novo Nordisk A/S; Måløv Denmark

2. Department of Veterinary and Animal Sciences; Faculty of Health and Medical Sciences; University of Copenhagen; Frederiksberg Denmark

3. Division of Experimental Hematology and Cancer Biology, Cancer and Blood Diseases Institute; Cincinnati Children's Research Foundation; Cincinnati OH USA

4. Department of Pharmacodynamics and Molecular Pharmacology; Faculty of Pharmacy; Collegium Medicum in Bydgoszcz; Nicolaus Copernicus University in Toruń; Toruń Poland

Funder

Novo Nordisk

Københavns Universitet

Innovationsfonden

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jth.14148/fullpdf

Reference56 articles.

1. What does it take to make the perfect clot?;Monroe;Arterioscler Thromb Vasc Biol,2006